132 related articles for article (PubMed ID: 11249132)
1. Stereoselective inhibition of glutamate carboxypeptidase by chiral phosphonothioic acids.
Lu H; Berkman CE
Bioorg Med Chem; 2001 Feb; 9(2):395-402. PubMed ID: 11249132
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective inhibition of glutamate carboxypeptidase by organophosphorus derivatives of glutamic acid.
Mallari JP; Choy CJ; Hu Y; Martinez AR; Hosaka M; Toriyabe Y; Maung J; Blecha JE; Pavkovic SF; Berkman CE
Bioorg Med Chem; 2004 Nov; 12(22):6011-20. PubMed ID: 15498677
[TBL] [Abstract][Full Text] [Related]
3. A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors.
Swierczek K; Pandey AS; Peters JW; Hengge AC
J Med Chem; 2003 Aug; 46(17):3703-8. PubMed ID: 12904075
[TBL] [Abstract][Full Text] [Related]
4. Phosphonate analogues of carboxypeptidase A substrates are potent transition-state analogue inhibitors.
Hanson JE; Kaplan AP; Bartlett PA
Biochemistry; 1989 Jul; 28(15):6294-305. PubMed ID: 2790000
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of glutamate carboxypeptidase II by phosphonamidothionate derivatives of glutamic acid.
Rodriguez CE; Lu H; Martinez AR; Hu Y; Brunelle A; Berkman CE
J Enzyme Inhib; 2001 Oct; 16(4):359-65. PubMed ID: 11916141
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of an inhibitor of carboxypeptidase A with a Ki value in the femtomolar range.
Kaplan AP; Bartlett PA
Biochemistry; 1991 Aug; 30(33):8165-70. PubMed ID: 1868091
[TBL] [Abstract][Full Text] [Related]
7. Cysteine derivatives as inhibitors for carboxypeptidase A: synthesis and structure-activity relationships.
Park JD; Kim DH
J Med Chem; 2002 Feb; 45(4):911-8. PubMed ID: 11831903
[TBL] [Abstract][Full Text] [Related]
8. Dual function glutamate-related ligands: discovery of a novel, potent inhibitor of glutamate carboxypeptidase II possessing mGluR3 agonist activity.
Nan F; Bzdega T; Pshenichkin S; Wroblewski JT; Wroblewska B; Neale JH; Kozikowski AP
J Med Chem; 2000 Mar; 43(5):772-4. PubMed ID: 10715144
[No Abstract] [Full Text] [Related]
9. Competitive inhibition of a glutamate carboxypeptidase by phosphonamidothionate derivatives of glutamic acid.
Rodriguez CE; Lu H; Dinh TT; Mlodnosky KL; Dastgah A; Lam VQ; Nichols CB; Berkman CE
Bioorg Med Chem Lett; 1999 May; 9(10):1415-8. PubMed ID: 10360747
[TBL] [Abstract][Full Text] [Related]
10. Aminophosphonic acids and derivatives. Synthesis and biological applications.
Orsini F; Sello G; Sisti M
Curr Med Chem; 2010; 17(3):264-89. PubMed ID: 20214568
[TBL] [Abstract][Full Text] [Related]
11. 3-Phosphonopropionic acids inhibit carboxypeptidase A as multisubstrate analogues or transition-state analogues.
Grobelny D; Goli UB; Galardy RE
Biochem J; 1985 Nov; 232(1):15-9. PubMed ID: 4084224
[TBL] [Abstract][Full Text] [Related]
12. Origin of chiral pharmacology: stereochemistry in metalloprotease inhibition.
Kim DH
Mini Rev Med Chem; 2001 Jul; 1(2):155-61. PubMed ID: 12369980
[TBL] [Abstract][Full Text] [Related]
13. A new type of carboxypeptidase A inhibitors designed using an imidazole as a zinc coordinating ligand.
Lee KJ; Joo KC; Kim EJ; Lee M; Kim DH
Bioorg Med Chem; 1997 Oct; 5(10):1989-98. PubMed ID: 9370042
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of the inhibitory activity of the four stereoisomers of the potent and selective human γ-glutamyl transpeptidase inhibitor GGsTop.
Watanabe B; Tabuchi Y; Wada K; Hiratake J
Bioorg Med Chem Lett; 2017 Nov; 27(21):4920-4924. PubMed ID: 28985998
[TBL] [Abstract][Full Text] [Related]
15. Potent and selective non-peptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action.
De Lombaert S; Blanchard L; Stamford LB; Tan J; Wallace EM; Satoh Y; Fitt J; Hoyer D; Simonsbergen D; Moliterni J; Marcopoulos N; Savage P; Chou M; Trapani AJ; Jeng AY
J Med Chem; 2000 Feb; 43(3):488-504. PubMed ID: 10669576
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.
Majer P; Jackson PF; Delahanty G; Grella BS; Ko YS; Li W; Liu Q; Maclin KM; Poláková J; Shaffer KA; Stoermer D; Vitharana D; Wang EY; Zakrzewski A; Rojas C; Slusher BS; Wozniak KM; Burak E; Limsakun T; Tsukamoto T
J Med Chem; 2003 May; 46(10):1989-96. PubMed ID: 12723961
[TBL] [Abstract][Full Text] [Related]
17. N-(Hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase A.
Chung SJ; Kim DH
Bioorg Med Chem; 2001 Jan; 9(1):185-9. PubMed ID: 11197339
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors.
Rong SB; Zhang J; Neale JH; Wroblewski JT; Wang S; Kozikowski AP
J Med Chem; 2002 Sep; 45(19):4140-52. PubMed ID: 12213057
[TBL] [Abstract][Full Text] [Related]
19. Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases.
Park JD; Kim DH; Kim SJ; Woo JR; Ryu SE
J Med Chem; 2002 Nov; 45(24):5295-302. PubMed ID: 12431056
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.
Kim IH; Park YK; Nishiwaki H; Hammock BD; Nishi K
Bioorg Med Chem; 2015 Nov; 23(22):7199-210. PubMed ID: 26507430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
